UniProt ID | TATD2_HUMAN | |
---|---|---|
UniProt AC | Q93075 | |
Protein Name | Putative deoxyribonuclease TATDN2 | |
Gene Name | TATDN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 761 | |
Subcellular Localization | Nucleus . | |
Protein Description | Putative deoxyribonuclease.. | |
Protein Sequence | MASERGKVKHNWSSTSEGCPRKRSCLREPCDVAPSSRPAQRSASRSGGPSSPKRLKAQKEDDVACSRRLSWGSSRRRNNSSSSFSPHFLGPGVGGAASKGCLIRNTRGFLSSGGSPLRPANASLEEMASLEEEACSLKVDSKDSSHNSTNSEFAAEAEGQNDTIEEPNKVQKRKRDRLRDQGSTMIYLKAIQGILGKSMPKRKGEAATRAKPSAAEHPSHGEGPARSEGPAKTAEGAARSVTVTAAQKEKDATPEVSMEEDKTVPERSSFYDRRVVIDPQEKPSEEPLGDRRTVIDKCSPPLEFLDDSDSHLEIQKHKDREVVMEHPSSGSDWSDVEEISTVRFSQEEPVSLKPSAVPEPSSFTTDYVMYPPHLYSSPWCDYASYWTSSPKPSSYPSTGSSSNDAAQVGKSSRSRMSDYSPNSTGSVQNTSRDMEASEEGWSQNSRSFRFSRSSEEREVKEKRTFQEEMPPRPCGGHASSSLPKSHLEPSLEEGFIDTHCHLDMLYSKLSFQGTFTKFRKIYSSSFPKEFQGCISDFCDPRTLTDCLWEELLKEDLVWGAFGCHPHFARYYSESQERNLLQALRHPKAVAFGEMGLDYSYKCTTPVPEQHKVFERQLQLAVSLKKPLVIHCREADEDLLEIMKKFVPPDYKIHRHCFTGSYPVIEPLLKYFPNMSVGFTAVLTYSSAWEAREALRQIPLERIIVETDAPYFLPRQVPKSLCQYAHPGLALHTVREIARVKDQPLSLTLAALRENTSRLYSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | GKVKHNWSSTSEGCP CCCCCCCCCCCCCCC | 29.11 | - | |
14 | Phosphorylation | KVKHNWSSTSEGCPR CCCCCCCCCCCCCCC | 27.80 | - | |
15 | Phosphorylation | VKHNWSSTSEGCPRK CCCCCCCCCCCCCCC | 25.86 | - | |
16 | Phosphorylation | KHNWSSTSEGCPRKR CCCCCCCCCCCCCCH | 33.66 | - | |
42 | Phosphorylation | SSRPAQRSASRSGGP CCCCCHHHHHHCCCC | 20.65 | 27251275 | |
44 | Phosphorylation | RPAQRSASRSGGPSS CCCHHHHHHCCCCCC | 28.38 | 27251275 | |
46 | Phosphorylation | AQRSASRSGGPSSPK CHHHHHHCCCCCCHH | 45.68 | 27251275 | |
50 | Phosphorylation | ASRSGGPSSPKRLKA HHHCCCCCCHHHHHC | 63.65 | 27251275 | |
51 | Phosphorylation | SRSGGPSSPKRLKAQ HHCCCCCCHHHHHCC | 37.26 | 28985074 | |
56 | Methylation | PSSPKRLKAQKEDDV CCCHHHHHCCCCCCC | 53.45 | 24129315 | |
70 | Phosphorylation | VACSRRLSWGSSRRR CHHHHHCCCCCCCCC | 27.81 | 25159151 | |
73 | Phosphorylation | SRRLSWGSSRRRNNS HHHCCCCCCCCCCCC | 17.89 | 30108239 | |
74 | Phosphorylation | RRLSWGSSRRRNNSS HHCCCCCCCCCCCCC | 26.35 | 30108239 | |
80 | Phosphorylation | SSRRRNNSSSSFSPH CCCCCCCCCCCCCCC | 34.84 | 23401153 | |
81 | Phosphorylation | SRRRNNSSSSFSPHF CCCCCCCCCCCCCCC | 31.93 | 25159151 | |
82 | Phosphorylation | RRRNNSSSSFSPHFL CCCCCCCCCCCCCCC | 34.91 | 28450419 | |
83 | Phosphorylation | RRNNSSSSFSPHFLG CCCCCCCCCCCCCCC | 31.52 | 28450419 | |
85 | Phosphorylation | NNSSSSFSPHFLGPG CCCCCCCCCCCCCCC | 21.29 | 28450419 | |
98 | Phosphorylation | PGVGGAASKGCLIRN CCCCCCHHCCCEEEC | 29.10 | 27251275 | |
111 | Phosphorylation | RNTRGFLSSGGSPLR ECCCCCHHCCCCCCC | 25.36 | 28387310 | |
112 | Phosphorylation | NTRGFLSSGGSPLRP CCCCCHHCCCCCCCC | 49.69 | 28450419 | |
115 | Phosphorylation | GFLSSGGSPLRPANA CCHHCCCCCCCCCCC | 25.04 | 22115753 | |
123 | Phosphorylation | PLRPANASLEEMASL CCCCCCCCHHHHHHC | 35.80 | 28450419 | |
129 | Phosphorylation | ASLEEMASLEEEACS CCHHHHHHCHHHHHC | 34.70 | 28102081 | |
183 | Phosphorylation | DRLRDQGSTMIYLKA HHHHHHCCHHHHHHH | 14.79 | 28450419 | |
184 | Phosphorylation | RLRDQGSTMIYLKAI HHHHHCCHHHHHHHH | 17.89 | 28450419 | |
197 | Acetylation | AIQGILGKSMPKRKG HHHHHHCCCCCCCCC | 39.89 | 25953088 | |
198 | Phosphorylation | IQGILGKSMPKRKGE HHHHHCCCCCCCCCC | 38.22 | 23909892 | |
211 | Ubiquitination | GEAATRAKPSAAEHP CCHHCCCCCCCCCCC | 35.89 | - | |
253 | Phosphorylation | AQKEKDATPEVSMEE HHHHCCCCCCCCCCC | 30.07 | 21815630 | |
257 | Phosphorylation | KDATPEVSMEEDKTV CCCCCCCCCCCCCCC | 20.86 | 25159151 | |
263 | Phosphorylation | VSMEEDKTVPERSSF CCCCCCCCCCCCCCC | 54.32 | 27251275 | |
293 | Phosphorylation | EPLGDRRTVIDKCSP CCCCCCCCCHHHCCC | 23.78 | 30266825 | |
299 | Phosphorylation | RTVIDKCSPPLEFLD CCCHHHCCCCHHHCC | 34.98 | 30266825 | |
308 | Phosphorylation | PLEFLDDSDSHLEIQ CHHHCCCCCCCEEEH | 40.45 | 30266825 | |
310 | Phosphorylation | EFLDDSDSHLEIQKH HHCCCCCCCEEEHHC | 33.64 | 30266825 | |
328 | Phosphorylation | EVVMEHPSSGSDWSD EEHHCCCCCCCCCHH | 49.60 | 27732954 | |
329 | Phosphorylation | VVMEHPSSGSDWSDV EHHCCCCCCCCCHHC | 46.93 | 27732954 | |
331 | Phosphorylation | MEHPSSGSDWSDVEE HCCCCCCCCCHHCCE | 37.54 | 27732954 | |
334 | Phosphorylation | PSSGSDWSDVEEIST CCCCCCCHHCCEEEE | 36.45 | 27732954 | |
340 | Phosphorylation | WSDVEEISTVRFSQE CHHCCEEEEEEECCC | 24.91 | 27732954 | |
341 | Phosphorylation | SDVEEISTVRFSQEE HHCCEEEEEEECCCC | 22.74 | 27732954 | |
393 | O-linked_Glycosylation | WTSSPKPSSYPSTGS CCCCCCCCCCCCCCC | 48.94 | 28411811 | |
397 | Phosphorylation | PKPSSYPSTGSSSND CCCCCCCCCCCCCCC | 36.85 | 27732954 | |
398 | Phosphorylation | KPSSYPSTGSSSNDA CCCCCCCCCCCCCCH | 36.26 | 27732954 | |
400 | Phosphorylation | SSYPSTGSSSNDAAQ CCCCCCCCCCCCHHH | 30.59 | 27732954 | |
401 | Phosphorylation | SYPSTGSSSNDAAQV CCCCCCCCCCCHHHH | 34.21 | 25627689 | |
402 | Phosphorylation | YPSTGSSSNDAAQVG CCCCCCCCCCHHHHC | 40.19 | 27732954 | |
417 | Phosphorylation | KSSRSRMSDYSPNST CCCHHCCCCCCCCCC | 32.08 | 30108239 | |
419 | Phosphorylation | SRSRMSDYSPNSTGS CHHCCCCCCCCCCCC | 20.79 | 30108239 | |
420 | Phosphorylation | RSRMSDYSPNSTGSV HHCCCCCCCCCCCCC | 23.69 | 21082442 | |
423 | Phosphorylation | MSDYSPNSTGSVQNT CCCCCCCCCCCCEEC | 37.21 | 30576142 | |
424 | Phosphorylation | SDYSPNSTGSVQNTS CCCCCCCCCCCEECC | 39.87 | 30108239 | |
426 | Phosphorylation | YSPNSTGSVQNTSRD CCCCCCCCCEECCCC | 22.18 | 27732954 | |
430 | Phosphorylation | STGSVQNTSRDMEAS CCCCCEECCCCCCHH | 14.19 | 27732954 | |
431 | Phosphorylation | TGSVQNTSRDMEASE CCCCEECCCCCCHHH | 33.56 | 30576142 | |
437 | Phosphorylation | TSRDMEASEEGWSQN CCCCCCHHHCCCCCC | 23.91 | 24114839 | |
442 | Phosphorylation | EASEEGWSQNSRSFR CHHHCCCCCCCCCCC | 30.27 | 24114839 | |
445 | Phosphorylation | EEGWSQNSRSFRFSR HCCCCCCCCCCCCCC | 22.97 | 24114839 | |
451 | Phosphorylation | NSRSFRFSRSSEERE CCCCCCCCCCHHHHH | 27.31 | 23403867 | |
453 | Phosphorylation | RSFRFSRSSEEREVK CCCCCCCCHHHHHHH | 40.69 | 23403867 | |
454 | Phosphorylation | SFRFSRSSEEREVKE CCCCCCCHHHHHHHH | 42.22 | 23403867 | |
464 | Phosphorylation | REVKEKRTFQEEMPP HHHHHHHCCCCCCCC | 40.51 | - | |
479 | Phosphorylation | RPCGGHASSSLPKSH CCCCCCCCCCCCHHH | 18.13 | 26699800 | |
480 | Phosphorylation | PCGGHASSSLPKSHL CCCCCCCCCCCHHHC | 36.36 | 26699800 | |
481 | Phosphorylation | CGGHASSSLPKSHLE CCCCCCCCCCHHHCC | 46.31 | 26699800 | |
517 | Ubiquitination | SFQGTFTKFRKIYSS HCCCCCHHHHHHHHC | 38.69 | - | |
528 | Ubiquitination | IYSSSFPKEFQGCIS HHHCCCCHHHCCHHH | 69.97 | - | |
611 | Ubiquitination | TPVPEQHKVFERQLQ CCCCHHHHHHHHHHH | 48.60 | - | |
625 | Ubiquitination | QLAVSLKKPLVIHCR HHHHHCCCCEEEEEE | 49.21 | - | |
643 | Ubiquitination | EDLLEIMKKFVPPDY HHHHHHHHHHCCCCC | 49.04 | - | |
644 | Ubiquitination | DLLEIMKKFVPPDYK HHHHHHHHHCCCCCE | 33.93 | - | |
651 | Ubiquitination | KFVPPDYKIHRHCFT HHCCCCCEEHHHHCC | 39.14 | - | |
718 | Ubiquitination | FLPRQVPKSLCQYAH CCCCCCCHHHHHHCC | 58.15 | - | |
740 | Ubiquitination | VREIARVKDQPLSLT HHHHHHCCCCCHHHH | 45.13 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TATD2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TATD2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TATD2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of TATD2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420, AND MASSSPECTROMETRY. |